Cancer (Tumor) Profiling Market Size, Share, Growth, and Industry Analysis, By Type ( Immunoassay, NGS, Mass Spectrometry, Others ), By Application ( Clinical, Research ), Regional Insights and Forecast to 2035

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Immunoassay
1.2.3 NGS
1.2.4 Mass Spectrometry
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Clinical
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer (Tumor) Profiling Market Perspective (2019-2030)
2.2 Global Cancer (Tumor) Profiling Growth Trends by Region
2.2.1 Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer (Tumor) Profiling Historic Market Size by Region (2019-2024)
2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Region (2025-2030)
2.3 Cancer (Tumor) Profiling Market Dynamics
2.3.1 Cancer (Tumor) Profiling Industry Trends
2.3.2 Cancer (Tumor) Profiling Market Drivers
2.3.3 Cancer (Tumor) Profiling Market Challenges
2.3.4 Cancer (Tumor) Profiling Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer (Tumor) Profiling by Players
3.1.1 Global Cancer (Tumor) Profiling Revenue by Players (2019-2024)
3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2019-2024)
3.2 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer (Tumor) Profiling, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cancer (Tumor) Profiling Market Concentration Ratio
3.4.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2023
3.5 Global Key Players of Cancer (Tumor) Profiling Head office and Area Served
3.6 Global Key Players of Cancer (Tumor) Profiling, Product and Application
3.7 Global Key Players of Cancer (Tumor) Profiling, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer (Tumor) Profiling Breakdown Data by Type
4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2019-2024)
4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2025-2030)
5 Cancer (Tumor) Profiling Breakdown Data by Application
5.1 Global Cancer (Tumor) Profiling Historic Market Size by Application (2019-2024)
5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer (Tumor) Profiling Market Size (2019-2030)
6.2 North America Cancer (Tumor) Profiling Market Size by Type
6.2.1 North America Cancer (Tumor) Profiling Market Size by Type (2019-2024)
6.2.2 North America Cancer (Tumor) Profiling Market Size by Type (2025-2030)
6.2.3 North America Cancer (Tumor) Profiling Market Share by Type (2019-2030)
6.3 North America Cancer (Tumor) Profiling Market Size by Application
6.3.1 North America Cancer (Tumor) Profiling Market Size by Application (2019-2024)
6.3.2 North America Cancer (Tumor) Profiling Market Size by Application (2025-2030)
6.3.3 North America Cancer (Tumor) Profiling Market Share by Application (2019-2030)
6.4 North America Cancer (Tumor) Profiling Market Size by Country
6.4.1 North America Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cancer (Tumor) Profiling Market Size by Country (2019-2024)
6.4.3 North America Cancer (Tumor) Profiling Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer (Tumor) Profiling Market Size (2019-2030)
7.2 Europe Cancer (Tumor) Profiling Market Size by Type
7.2.1 Europe Cancer (Tumor) Profiling Market Size by Type (2019-2024)
7.2.2 Europe Cancer (Tumor) Profiling Market Size by Type (2025-2030)
7.2.3 Europe Cancer (Tumor) Profiling Market Share by Type (2019-2030)
7.3 Europe Cancer (Tumor) Profiling Market Size by Application
7.3.1 Europe Cancer (Tumor) Profiling Market Size by Application (2019-2024)
7.3.2 Europe Cancer (Tumor) Profiling Market Size by Application (2025-2030)
7.3.3 Europe Cancer (Tumor) Profiling Market Share by Application (2019-2030)
7.4 Europe Cancer (Tumor) Profiling Market Size by Country
7.4.1 Europe Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cancer (Tumor) Profiling Market Size by Country (2019-2024)
7.4.3 Europe Cancer (Tumor) Profiling Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer (Tumor) Profiling Market Size (2019-2030)
8.2 China Cancer (Tumor) Profiling Market Size by Type
8.2.1 China Cancer (Tumor) Profiling Market Size by Type (2019-2024)
8.2.2 China Cancer (Tumor) Profiling Market Size by Type (2025-2030)
8.2.3 China Cancer (Tumor) Profiling Market Share by Type (2019-2030)
8.3 China Cancer (Tumor) Profiling Market Size by Application
8.3.1 China Cancer (Tumor) Profiling Market Size by Application (2019-2024)
8.3.2 China Cancer (Tumor) Profiling Market Size by Application (2025-2030)
8.3.3 China Cancer (Tumor) Profiling Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cancer (Tumor) Profiling Market Size (2019-2030)
9.2 Asia Cancer (Tumor) Profiling Market Size by Type
9.2.1 Asia Cancer (Tumor) Profiling Market Size by Type (2019-2024)
9.2.2 Asia Cancer (Tumor) Profiling Market Size by Type (2025-2030)
9.2.3 Asia Cancer (Tumor) Profiling Market Share by Type (2019-2030)
9.3 Asia Cancer (Tumor) Profiling Market Size by Application
9.3.1 Asia Cancer (Tumor) Profiling Market Size by Application (2019-2024)
9.3.2 Asia Cancer (Tumor) Profiling Market Size by Application (2025-2030)
9.3.3 Asia Cancer (Tumor) Profiling Market Share by Application (2019-2030)
9.4 Asia Cancer (Tumor) Profiling Market Size by Region
9.4.1 Asia Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cancer (Tumor) Profiling Market Size by Region (2019-2024)
9.4.3 Asia Cancer (Tumor) Profiling Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Cancer (Tumor) Profiling Introduction
11.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.1.5 Illumina Recent Developments
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Cancer (Tumor) Profiling Introduction
11.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.2.5 Qiagen Recent Developments
11.3 Neogenomics Laboratories
11.3.1 Neogenomics Laboratories Company Details
11.3.2 Neogenomics Laboratories Business Overview
11.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
11.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.3.5 Neogenomics Laboratories Recent Developments
11.4 HTG Molecular Diagnostics
11.4.1 HTG Molecular Diagnostics Company Details
11.4.2 HTG Molecular Diagnostics Business Overview
11.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
11.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.4.5 HTG Molecular Diagnostics Recent Developments
11.5 Genomic Health
11.5.1 Genomic Health Company Details
11.5.2 Genomic Health Business Overview
11.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
11.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.5.5 Genomic Health Recent Developments
11.6 Caris Life Sciences
11.6.1 Caris Life Sciences Company Details
11.6.2 Caris Life Sciences Business Overview
11.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
11.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.6.5 Caris Life Sciences Recent Developments
11.7 Helomics Corporation
11.7.1 Helomics Corporation Company Details
11.7.2 Helomics Corporation Business Overview
11.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
11.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.7.5 Helomics Corporation Recent Developments
11.8 Nanostring Technologies
11.8.1 Nanostring Technologies Company Details
11.8.2 Nanostring Technologies Business Overview
11.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
11.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.8.5 Nanostring Technologies Recent Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Details
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
11.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.9.5 Oxford Gene Technology Recent Developments
11.10 Ribomed Biotechnologies
11.10.1 Ribomed Biotechnologies Company Details
11.10.2 Ribomed Biotechnologies Business Overview
11.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
11.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2019-2024)
11.10.5 Ribomed Biotechnologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details